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Well differentiated keratinising nasopharyn-
geal carcinoma (NPC) (WHO type 1)' is much
rarer than the undifferentiated type (WHO
type 3) in high incidence areas such as Hong
Kong. It accounts for about 2% ofNPC cases
seen in our department. Probably because of
the paucity of cases, the relation of Epstein-
Barr virus (EBV) to this tumour has been less
frequently studied. Patients with this form of
NPC showEBV antibody titres similar to those
of control populations,' in contrast to the raised
titres seen in patients with the undifferentiated
variety. Although EBV serology is not helpful
in the diagnosis of this tumour, molecular
biological techniques can be used to study the
relation between the tumour and the virus. The
aim of this study was to determine if the EBV
Sequences of oligonucleotide primers and probe usedfor the amplification ofEBVDNA'
Sequence (5' >3') Size of amplifiedproduct (bp)
A CCAGAGGTAAGTGGACTT (18 mer) 122
B GACCGGTGCCTTCTTAGG (18 mer)
Probe: TTCTGCTAAGCCCAAC (16 mer)
genome could be detected in well differentiated
NPC in Chinese patients in Hong Kong using
DNA slot-blot hybridisation and the
polymerase chain reaction (PCR) on archival
formalin-fixed paraffin wax embedded tissue.
Methods
Selection of cases
Eight cases of undifferentiated nasopharyngeal
carcinoma conforming toWHO type 3 criteria,
eight cases of well differentiated keratinising
squamous carcinoma (WHO type 1), and eight
normal nasopharyngeal biopsy specimens were
selected from the files of the Department of
Pathology, University of Hong Kong. The
slides were reviewed and the diagnosis and
typing of the malignant biopsy specimens con-
firmed. Care was taken that these consisted
almost entirely of tumour with a minimal
amount of lymphoid tissue or nasopharyngeal
mucosa present.
DNA slot-blot hybridisation analysis
Two sections 16 jm thick were cut from each
sample and dewaxed. The genomic DNA was
extracted using proteinase K and denatured
DNA was slot-blotted on a nylon membrane.34
The presence of EBV genome was detected
using a 32P-labelled 3-1 kilobase B95-8 internal
repeat BamW probe with hybridisation and
washing conditions as reported.34
PCR Analysis
The oligonucleotide primers used to amplify
EBVDNA were within the first internal repeat
(IRl) fragment ofEBVDNA from base 1399 to
1520. The oligonucleotide probe spans the
intervening region within the first internal
repeat (IRI) from base 1424 to 1439 (table).5
DNA amplification was carried out using the
DNA amplification reagent kit with native Taq
DNA polymerase (Gene Amp, Perkin Elmer
Cetus) using conditions reported previously.6
The amplified products were analysed by
Southern blotting of the gel followed by prob-
ing of the membrane with 32P-labelled
oligomeric probe specific for amplified EBV
DNA. The hybridisation and washing condi-
tions were as previously reported.6 DNA
extracted from EBV-infected Burkitt's lym-
phoid cell line, Raji, was used as a positive
control. SiHa cell line DNA was the negative
control. Raji and SiHa cell lines were obtained
from the American Tissue Culture Collection.
Results and discussion
The results ofDNA slot-blot hybridisation for
the presence ofEBV genome using unamplified
Abstract
Aims: To investigate the presence of
Epstein-Barr virus (EBV) in cases of
nasopharyngeal carcinoma (NPC) in
Chinese patients living in Hong Kong.
Methods: Nasopharyngeal biopsy
specimens, formalin fixed and paraffin
wax embedded, from 24 patients, eight
with undifferentiated nasopharyngeal
carcinoma, eight with well differentiated
squamous carcinoma, and eight showing
normal tissue histology, were analysed
for the presence of Epstein-Barr virus
(EBV) DNA by slot-blot hybridisation on
extracted unamplified DNA, and also
after amplification of EBV specific
sequences by the polymerase chain reac-
tion (PCR).
Results: DNA slot-blot analysis showed
viral DNA in all the undifferentiated, five
of the well differentiated tumours, and
none of the normal biopsy specimens.
PCR studies confirmed positivity in the
eight undifferentiated tumours, but six of
the well differentiated tumours and three
of the normal biopsy specimens showed
viral DNA by this method, illustrating its
greater sensitivity.
Conclusions: EBV genome is present in
appreciable copy number in most cases of
well differentiated NPC in Chinese
patients in Hong Kong.
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EBV in NPC ofHong Kong Chinese
WELL-DIF RENTIATED NPC DNA showed viral DNA in all eight cases of
undifferentiated NPC, five of the well differen-
tiated cases (cases 1, 4, 5, 6 and 7) but none of
the normal biopsy samples (fig 1). The PCR
1 2 3 4 5 6 7 8 analysis showed similar results in the
undifferentiated cases but one additional well
_*>;S~-w ^_ differentiated tumour (case 2) was positive and
three of the normal biopsy specimens (cases 17,
18 and 20) showed the presence of EBV DNA
(fig 2).
The association of undifferentiated NPC
with EBV is well established. Using DNA in
situ hybridisation, the viral genome has been
UNDI F RENTIATED NPC demonstrated in the tumour cells.7'8 The well
differentiated form of NPC has also been
shown to contain EBV, although in very low
9 10 11 12 13 14 15 16 copy number, by direct Southern blotting
using frozen biopsy samples from Caucasian
patients.9 Our results, using paraffin wax
embedded tissue from Asians, indicate that
even with the relatively simple technique of
DNA slot-blot hybridisation EBV DNA can be
readily detected in most cases of well differen-
tiated NPC whereas normal biopsy specimens
are consistently negative and undifferentiated
NORMAL NASOPHARYNGEAL BIOPSY NPC cases are consistently positive (as expec-
ted). The PCR analysis confirmed the slot-blot
findings and the greater sensitivity of this
17 18 19 20 21 22 23 24 technique would explain the finding of EBV
DNA in one additional case of well differen-
tiated NPC and in three of the normal biopsy
specimens. This latter result is consistent with
a previous report of EBV DNA detection in
Figure 1 Results of the DNA slot-blot hybridisation for the presence of EBVgenome exfoliated nasopharyngeal cells from normal
using unamplifedDNA samples. Chinese subjects who have normal ranges of
WELL-DIFFERENTIATED NPC Lon.er EBV antibody titres.10 The negativity of the
Exposure eight normal samples by slot-blotting suggests
a very low copy number in these biopsy
1 2 3 4 5 6 7 8 2 6 specimens.
We conclude that EBV DNA is present in
v Lmost cases of well differentiated NPC in Chin-
ese patients in Hong Kong and in appreciable
copy number, although not as high as in the
undifferentiated tumours. This suggests that,
regardless of the histological type, NPC is an
EBV-associated malignancy.
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